Innovative Targeting Solutions Inc. (InnoTarg) is focused on the development of novel human antibody technologies. ITS' platform is capable of "de novo" antibody generation; and, for the first time, allows for mammalian display repertoires of >10^9 to be exploited effectively. (BIOTECanada)(LSBC)